Conversely, other studies suggest a negative association between serum sclerostin levels and BMD [63,64], with elevated circulating sclerostin levels identified as a strong and independent risk factor for osteoporosis-related fractures in postmenopausal women [65]. This evidence concerns the gene SOST and osteoporosis.